News
CSII
13.57
+1.38%
0.19
Cardiovascular Systems First Quarter 2023 Earnings: EPS Misses Expectations
Cardiovascular Systems ( NASDAQ:CSII ) First Quarter 2023 Results Key Financial Results Revenue: US$59.7m (up 2.2% from...
Simply Wall St. · 11/09 10:34
Cardiovascular Systems (CSII) Reports Q1 Loss, Tops Revenue Estimates
Cardiovascular Systems (CSII) delivered earnings and revenue surprises of -12.50% and 0.58%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 11/03 12:35
Cardiovascular Systems: Q1 Earnings Insights
Benzinga · 11/03 11:38
Cardiovascular Systems GAAP EPS of -$0.27 misses by $0.04, revenue of $59.67M beats by $0.33M
Seekingalpha · 11/03 11:14
BRIEF-Cardiovascular Systems, Inc. Reports Fiscal 2023 First Quarter Financial Results
Reuters · 11/03 11:08
Cardiovascular Systems Q1 EPS $(0.27) Misses $(0.23) Estimate, Sales $59.67M Beat $59.14M Estimate
Benzinga · 11/03 11:01
Cardiovascular Systems, Inc. Reports Fiscal 2023 First Quarter Financial Results
ST. PAUL, Minn., November 03, 2022--CARDIOVASCULAR SYSTEMS, INC. REPORTS FISCAL 2023 FIRST QUARTER FINANCIAL RESULTS
Business Wire · 11/03 11:00
-- Earnings Flash (CSII) CARDIOVASCULAR SYSTEMS Posts Q1 Revenue $59.7M, vs. Street Est of $59.3M
-- Earnings Flash (CSII) CARDIOVASCULAR SYSTEMS Posts Q1 Revenue $59.7M, vs. Street Est of $59.3M
MT Newswires · 11/03 07:21
Cardiovascular Systems (CSII) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Cardiovascular Systems (CSII) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 10/27 14:02
Cardiovascular Systems, Inc. Announces Full Market Release of the 2.00 Max Crown for Peripheral Orbital Atherectomy Systems
ST. PAUL, Minn., October 17, 2022--CARDIOVASCULAR SYSTEMS, INC. ANNOUNCES FULL MARKET RELEASE OF THE 2.00 MAX CROWN PERIPHERAL ORBITAL ATHERECTOMY SYSTEM
Business Wire · 10/17 11:00
Cardiovascular Systems, Inc. to Host Earnings Conference Call on November 3, 2022
ST. PAUL, Minn., October 12, 2022--CARDIOVASCULAR SYSTEMS, INC. TO HOST EARNINGS CONFERENCE CALL ON NOVEMBER 3, 2022
Business Wire · 10/12 11:00
Cardiovascular Systems (CSII) Q4 Earnings, Revenues Miss Mark
According to Cardiovascular Systems (CSII), strong sequential growth in each of its segments is due to procedure recovery, focused commercial strategies and the launch of products.
Zacks · 08/08 13:09
Cardiovascular Systems Widens Fiscal Q4 Net Loss as Revenue Falls; Issues Fiscal 2023 Outlook; Shares Gain
Cardiovascular Systems Widens Fiscal Q4 Net Loss as Revenue Falls; Issues Fiscal 2023 Outlook; Shares Gain
MT Newswires · 08/03 14:12
Cardiovascular Systems reports Q4 earnings miss; provides FY23 revenue guidance in-line with estimates
Cardiovascular Systems press release (<span ...
Seekingalpha · 08/03 04:19
Cardiovascular Systems Posts Wider Fiscal Q4 Loss as Revenue Declines
Cardiovascular Systems Posts Wider Fiscal Q4 Loss as Revenue Declines
MT Newswires · 08/03 03:21
BRIEF-Cardiovascular Systems, Inc Reports Fourth-Quarter Net Loss Of $9.7 Million, Or $0.25 Per Basic And Diluted Share
BRIEF-Cardiovascular Systems, Inc Reports Fourth-Quarter Net Loss Of $9.7 Million, Or $0.25 Per Basic And Diluted Share
Reuters · 08/03 00:32
Shareholders in Cardiovascular Systems (NASDAQ:CSII) are in the red if they invested a year ago
Even the best stock pickers will make plenty of bad investments. And unfortunately for Cardiovascular Systems, Inc...
Simply Wall St. · 07/04 11:12
QuidelOrtho (QDEL) Stock Jumps 3.9%: Will It Continue to Soar?
QuidelOrtho (QDEL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks · 06/20 12:59
Cardiovascular Systems chief operating officer Rhonda Robb exits company
Cardiovascular Systems (NASDAQ:CSII) said on Tuesday its chief operating officer Rhonda Robb's employment with the company had ended on Monday. The company said in a form 8-K filing on Tuesday. The company said
Seekingalpha · 06/07 21:04
Cardiovascular Systems (CSII) Up 0.9% Since Last Earnings Report: Can It Continue?
Cardiovascular Systems (CSII) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks · 06/03 15:32
More
Webull provides a variety of real-time CSII stock news. You can receive the latest news about Cardiovascular through multiple platforms. This information may help you make smarter investment decisions.
About CSII
Cardiovascular Systems, Inc. is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company has developed orbital atherectomy systems (OAS) for both peripheral and coronary clinical applications. The primary base of its business is catheter-based platforms capable of treating a range of vessel sizes and plaque types, including calcified plaque. Its peripheral artery disease (PAD) products are catheter-based platforms capable of treating a range of plaque types in leg arteries both above and below the knee, including calcified plaque. Its coronary artery disease (CAD) product, the Diamondback 360 Coronary OAS (Coronary OAS), is a catheter-based platform designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to de novo, severely calcified coronary artery lesions.